Bivalent S-Trimer COVID-19 Vaccine (Clover Biopharmaceuticals)

二价刺突蛋白三聚体COVID-19疫苗（三叶草生物）

Report date: 2022/05/06 15:13:48

Base Information

Drug NameBivalent S-Trimer COVID-19 Vaccine (Clover Biopharmaceuticals)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesClover Biopharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesClover Biopharmaceuticals Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A